Lifecore Biomedical, Inc. (LFCR) Total Assets by Year
Lifecore Biomedical, Inc. closed fiscal year 2025 with $239.3M in total assets, $240.2M in total liabilities and -$861K in shareholder equity. This represents a decrease of 5.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lifecore Biomedical, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LFCR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $239.3M-5.8% | $254.0M+0.2% | $253.5M-7.7% | $274.7M-45.3% | $501.9M+71.0% | $293.5M-43.5% | $519.1M+28.3% | $404.7M+12.9% | $358.6M+4.7% | $342.7M-1.1% | $346.5M+10.5% | $313.6M+7.8% | $290.9M+4.8% | $277.7M+34.6% | $206.3M |
| Total Liabilities | $240.2M+20.1% | $200.1M-8.4% | $218.5M+16.9% | $186.9M-37.7% | $299.9M+371.1% | $63.7M-74.4% | $248.9M+63.6% | $152.1M+16.6% | $130.5M+0.1% | $130.3M+3.1% | $126.4M+16.1% | $108.9M-1.5% | $110.5M-12.4% | $126.1M+83.9% | $68.6M |
| Total Equity | -$861K-107.6% | $11.3M+367.5% | -$4.2M-104.8% | $87.8M-56.5% | $201.9M-12.1% | $229.8M-14.9% | $270.1M+7.0% | $252.6M+11.5% | $226.6M+7.5% | $210.7M-3.5% | $218.4M+7.6% | $203.1M+13.6% | $178.7M+19.3% | $149.7M+10.1% | $136.1M |
LFCR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $229.5M | $225.5M-5.8% | $232.2M-2.3% | $235.2M-7.9% | $239.3M-5.8% | $237.7M-3.5% | $255.4M+3.9% | $246.8M+0.5% | $254.0M+0.2% | $246.2M+4.1% | $245.8M-10.9% | $245.6M-7.8% |
| Total Liabilities | $263.6M | $253.9M+5.7% | $246.4M+29.5% | $245.7M+25.6% | $240.2M+20.1% | $190.3M+1.9% | $195.6M-3.9% | $207.3M-5.4% | $200.1M-8.4% | $186.8M+14.5% | $203.5M-0.7% | $219.1M+16.2% |
| Total Equity | -$34.1M | -$28.4M-3202.9% | -$14.2M-739.4% | -$10.5M-168.2% | -$861K-107.6% | $2.2M-87.4% | $15.4M+987.2% | -$3.9M+71.0% | $11.3M+367.5% | $17.7M-49.5% | $1.4M-98.0% | -$13.6M-117.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Lifecore Biomedical, Inc. financials
Frequently Asked Questions
What was Lifecore Biomedical, Inc.'s total assets in fiscal year 2025?
Lifecore Biomedical, Inc. closed fiscal year 2025 with $239.3M in total assets, $240.2M in total liabilities and -$861K in shareholder equity.
How fast is Lifecore Biomedical, Inc.'s total assets growing?
Lifecore Biomedical, Inc. (LFCR) total assets fell by 5.8% year over year, from $254.0M to $239.3M in fiscal year 2025.
How has Lifecore Biomedical, Inc.'s total assets changed over the years?
Across the 15 fiscal years this page covers, Lifecore Biomedical, Inc. (LFCR) total assets went from $206.3M in fiscal year 2011 to $239.3M in fiscal year 2025.
What was Lifecore Biomedical, Inc.'s total assets in the most recent quarter?
Lifecore Biomedical, Inc. (LFCR) reported $229.5M in total assets in Q1 2027.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Lifecore Biomedical, Inc. (LFCR) reported on that line in every period on record.